市場調查報告書
商品編碼
1439660
手術雷射 - 全球市場考量、競爭狀況、市場預測 (2030)Surgical Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023年全球手術雷射器市場規模將達到18.3167億美元,2030年將達到27.7261億美元,預計2024-2030年期間複合年增長率為7.26%。 由於技術進步、急性和慢性疾病,特別是眼科和腫瘤疾病的發病率和盛行率的增加,市場呈現出積極的增長。 此外,在2024-2030年的預測期內,廣泛的應用、對微創手術的日益偏好以及老年人口的增加都將促進手術雷射市場的成長。
手術雷射市場動態
在手術雷射市場,由於多種原因,產品需求不斷增加。 主要因素包括世界各地產品領域的技術進步和產品發佈。
例如,2022 年 9 月,蔡司發佈了 ZEISS VISUMAX 800。 這種新一代飛秒雷射透過數位連接的角膜屈光工作流程,透過輕鬆的治療計劃和數據分析來減少雷射時間和潛在的轉錄錯誤,從而為患者和外科醫生提供舒適的體驗。
此外,LENSAR還推出了用於白內障手術的下一代飛秒雷射技術-ALLY(TM)系統,並在2022年美國白內障和屈光手術學會(ASCRS)年會上公佈了多項數據。 LENSAR 計劃於 2022 年第一季提交 510(k) 申請,以獲得 ALLY 的監管批准,預計於 2022 年下半年投入商業使用。
2020 年 7 月,SCHWIND Eye-tech 解決方案的 SCHWIND ATOS 飛秒雷射器獲得了 CE 批准。
此外,由於微創手術日益普及,手術雷射市場的產品需求正在激增。 儘管開放性手術仍然是標準手術,但開放性手術的缺點,例如手術併發症風險增加和癒合時間長,成為微創手術發展的催化劑。 手術雷射具有精確性、穩定性和與現代技術的集成,以及針對個別手術專業的多種其他優勢。 因此,此類系統預計將徹底改變外科領域。 因此,由於手術雷射在醫療領域的優勢,預計2024-2030年預測期內手術雷射市場的成長前景將是良好的。
然而,雷射設備的高成本以及與雷射相關的安全問題等某些因素可能會對手術雷射市場的成長產生一定的限制。
COVID-19 大流行的爆發對世界各地產生了重大影響。 由於 COVID-19 大流行,患者非常不願意接受白內障和屈光手術等選擇性治療。 手術數量明顯減少。 一項研究顯示,2020年3月下半月,全球手術數量比2019年同期減少了25%,就診患者數量減少了約50%。 一旦解除封鎖限制,所有專業對手術雷射的需求都激增。 這導致大流行後全球手術雷射市場加速成長。
手術雷射市場細分分析
在手術雷射市場的手術領域,CO2氣體雷射系統預計在預測期內(2024-2030年)將佔較高佔有率。 這可能是由於與這些雷射相關的特性所造成的。
該產品領域的龐大市場佔有率可歸因於患者採用這些設備和快速治療。 CO2 氣體雷射系統的主要優點是它們能夠以相對效率產生非常高的功率。 因此,它主要用於材料加工應用。
本報告提供了全球手術雷射市場的研究和分析,包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。
Surgical Lasers Market By Product (Solid-State Laser Systems [Erbium Yttrium Aluminum Garnet (ER: YAG), Neodymium Yttrium Aluminum Garnet (ND: YAG), Holmium Yttrium Aluminum Garnet (HO: YAG), Others], Gas Laser Systems [Co2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the technological advancements and growing preference for minimally invasive surgeries
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030. The Surgical Lasers market is witnessing positive growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly ophthalmic disorders and oncological disorders. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population are thereby contributing to the growth of the Surgical Lasers market during the forecast period from 2024-2030.
Surgical Lasers Market Dynamics:
The Surgical Lasers market is witnessing a growth in product demand owing to various reasons. The key factor includes the technological advancements and product launches that are taking place in the product arena across the globe.
For instance, in September 2022, ZEISS introduced the ZEISS VISUMAX 800, the next generation femtosecond lasers that create a comfortable patient and surgeon experience by reducing laser time and potential transcription errors with easy treatment planning and data analysis via a digitally connected corneal refractive workflow.
In addition, LENSAR announced its next-generation femtosecond laser technology ALLY(TM) System, used in cataract surgery, and presented multiple data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 Annual Meeting. LENSAR expects to submit a 510(k) application for regulatory clearance of ALLY in the first quarter of 2022, with a commercial launch planned for later in 2022.
In July 2020, SCHWIND eye-tech solutions received CE approval for the SCHWIND ATOS femtosecond laser.
Moreover, the Surgical Lasers market is witnessing a surge in product demand due to the growing popularity of minimally invasive procedures. Even though open surgeries are still a norm, the disadvantages associated with open surgery such as the increased risk of procedural complications, longer healing time acted as a catalyst in the development of minimally invasive procedures. Surgical Lasers offer accuracy, stability, integration with modern technology, in addition to multiple other benefits exclusive to individual surgical specialties. As a result, such systems are expected to revolutionize the field of surgery. Thus, owing to the advantages associated with surgical lasers in the medical field, the growth prospect of the Surgical Lasers market appears to be lucrative during the forecast period from 2024-2030.
However, certain factors such as the high cost of laser devices and the safety concerns associated with lasers may be certain limiting factors of the Surgical Lasers market growth.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. Patients were highly unwilling to seek elective health treatment, such as cataracts and refractive surgery, as a result of the COVID-19 epidemic. The number of surgeries performed decreased considerably. As per the research studies, in the second half of March 2020, 25% fewer surgical operations were done than in the same time in 2019, and the number of patients seen in the clinic fell by roughly 50% globally. Once the lockdown restrictions were uplifted, the demand surged across all the specialty areas for surgical lasers. This led to accelerating the growth of the Global Surgical Lasers market post-pandemic.
Surgical Lasers Market Segment Analysis:
Surgical Lasers Market By Product (Solid-state Laser Systems [Erbium Yttrium Aluminum Garnet (Er: YAG), Neodymium Yttrium Aluminum Garnet (Nd: YAG), Holmium Yttrium Aluminum Garnet (Ho: YAG), Others], Gas Laser Systems [CO2, Argon, Excimer, Others], Diode Laser Systems, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Percutaneous Surgery, Others), By Application (Cosmetic, Dental, Ophthalmic, Gynecology, others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Procedure segment of the Surgical Lasers market, the CO2 Gas Laser Systems is estimated to hold a higher share in the Surgical Lasers market during the forecast period (2024-2030). This can be attributed to the specific features associated with these lasers.
The large market share of this product segment can be attributed to the growing patient adoption of these devices and quick treatment. The main benefit of CO2 Gas Laser Systems is that it produces very high power with relative efficiency. Hence it is used primarily for materials processing applications.
CO2 laser offers low cost per watt in addition to good beam quality. It generates high power output which ranges from a few watts to 15 KWatts.
Another major advantage of using the CO2 laser is the minimized charring with faster healing which increases patients' motivation for treatment, but caution is necessary with regard to recurrence.
Therefore, it is expected that with such advantages offered by the CO2 Gas Laser Systems, this product is expected to increase its penetration in coming years, thus this will drive the segment to grow during the forecast period, which will have a positive impact on the overall Global Surgical Lasers Market growth.
Furthermore, CO2 Gas Laser Systems are gaining commercial acceptability, which also improves market penetration. All these advantages of such devices make physicians more inclined to use CO2 Gas Laser Systems.
Hence, all the above-mentioned factors are expected to drive the segment growth of the Surgical Lasers market.
North America is expected to dominate the overall Surgical Lasers Market:
Among all the regions, North America is expected to account for the largest share in the Global Surgical Lasers market. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region are expected to aid in the growth of the North America Surgical Lasers Market.
As per CDC 2020, approximately 12 million people 40 years and over in the United States have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error.
Additionally, according to Cancer Vision 2020, based on the trends in the surgical volume of cataract surgery over the past decade, 3.7 million cataract cases would have been performed in 2020 in the United States among Medicare beneficiaries.
According to the New Plastic Surgery Statistics released by the American Society of Plastic Surgeons (ASPS) shows there were nearly a quarter-million more cosmetic procedures performed in 2018 than in the year 2017. Also, according to the ASPS annual plastic surgery statistics report, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States in 2018. The statistics also revealed a rise in new trends in body-shaping procedures, with a spike in non-invasive fat reduction, as well as surgeries such as breast augmentations and liposuction.
Hence, Minimally Invasive Surgery approaches such as the use of Surgical Lasers are gaining popularity owing to their precision and minimal invasion in the surrounding anatomy. Furthermore, Surgical Lasers are being preferred by surgeons for conducting numerous surgical procedures due to aided benefits of precision and accuracy and better chances of reproducing positive surgical outcomes which further helps in faster recovery for patients. Therefore, the Surgical Lasers market is slated to register remarkable growth during the forecast period (2024-2030) owing to the factors mentioned above.
Another factor responsible for the growth of the Surgical Lasers market is the launch of new products in the region. For instance, in March 2019, Sciton Inc., a manufacturer of aesthetic and medical laser and light source technology, launched the latest version of its flagship platform JOULE X at the American Society of Laser Medicine and Surgery (ASLMS) annual meeting in Colorado., Canada. JOULE X is a multi-device platform with customizable laser and light performance.
Thus, these factors are projected to contribute to the Surgical Lasers market during the forecast period.
The rising adoption of Surgical Lasers in the country would result in the rising demand for procedures that make use of Surgical Lasers, which in turn would provide a conducive growth environment for the United States Surgical Lasers market as well as the North American region. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Surgical Lasers market during the forecast period.
Surgical Lasers Market Key Players:
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
Recent Developmental Activities in the Surgical Lasers Market:
In September 2022, Boston Scientific announced the closure of its acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures with total revenue anticipated to be approximately $200 million for full-year 2022.
Key Takeaways from the Surgical Lasers Market Report Study
Target Audience who can be benefited from this Surgical Lasers Market Report Study
Frequently Asked Questions for the Surgical Lasers Market:
According to FDA, Surgical Lasers are devices used to precisely focus light sources to treat or remove tissues. Because lasers can focus very accurately on tiny areas, they can be used for very precise surgical work or for cutting through tissue.
The global surgical lasers market was valued at USD 1,831.67 million in 2023, growing at a CAGR of 7.26% during the forecast period from 2024 to 2030 to reach USD 2,772.61 million by 2030.
The Surgical Lasers market is witnessing a positive market growth owing to the technological advancements, increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of applications, growing preference for minimally invasive surgeries, rising geriatric population is thereby contributing to the growth of the Surgical Lasers market.
Some of the key market players operating in the Surgical Lasers market include LightScalpel, Quanta System, KLS Martin Group, Lumenis Be Ltd. (Boston Scientific Corporation), INTERmedic Arfran, Cynosure (Hologic), Alma Lasers, Johnson & Johnson Vision Care, Inc., IPG Photonics Corporation, Koninklijke Philips N.V., biolitec® AG, Fotona, BISON MEDICAL, Alcon Laboratories, Inc., A.R.C. Laser GmbH, Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, MEDA Co., Ltd., LIGHTMED, NIDEK CO., LTD., and others.
North America is expected to hold the highest share in the revenue in the Surgical Lasers market during the forecast period. Factors such as the increasing incidence and prevalence of acute and chronic disorders, particularly in ophthalmic disorders and oncological disorders among others. In addition, a wide variety of surgical applications and rising product launches in the region, are expected to aid in the growth of the North America Surgical Lasers Market in this region.